Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
28.85
-0.19 (-0.65%)
May 30, 2025, 4:00 PM - Market closed
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $2.21 billion as of May 30, 2025. Its market cap has decreased by -27.54% in one year.
Market Cap
2.21B
Enterprise Value
1.53B
1-Year Change
-27.54%
Ranking
Category
Stock Price
$28.85
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $2.21B, an increase of 1,456.80%. That is a compound annual growth rate of 29.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 2.23B | -25.44% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 648.68B |
| Johnson & Johnson | 369.52B |
| AbbVie | 327.88B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.48B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 219.70B |
| AstraZeneca | 217.50B |